Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus-Like Particle Uptake and Presentation by Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo

by Kirsi Tamminen, Suvi Heinimäki, Timo Vesikari, Vesna Blazevic
Published 2020-01-01

Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune...

by Suvi Heinimäki, Maria Malm, Timo Vesikari, Vesna Blazevic
Published 2018-01-01

Fusion Protein of Rotavirus VP6 and SARS-CoV-2 Receptor Binding Domain Induces T Cell Responses

by Kirsi Tamminen, Suvi Heinimäki, Stina Gröhn, Vesna Blazevic
Published 2021-07-01

Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations with Particulate Antigens Only

by Suvi Heinimäki, Kirsi Tamminen, Vesa P. Hytönen, Maria Malm, Vesna Blazevic
Published 2020-07-01

Modular vaccine platform based on the norovirus-like particle

by Vili Lampinen, Suvi Heinimäki, Olli H. Laitinen, Marko Pesu, Minna M. Hankaniemi, Vesna Blazevic, Vesa P. Hytönen
Published 2021-01-01